|NIAMS at 20
Throughout our 20-year history, NIAMS has supported research
and programs that have improved the lives of people with some of
the most chronic, costly and common disorders of our time. A sampling
of the institute's successes might include:
- The discovery that treatment with cyclophosphamide and prednisone
prevents or delays kidney failure due to lupus nephritis, one
of the most serious complications of the disease.
- A registry for people with the blistering skin disorder epidermolysis
bullosa that resulted in new diagnostic methods, disease criteria
and a technique for wound-healing in certain forms of the disease.
the outset, we gave high priority to research on women’s
and minority health in such diseases as osteoporosis,
lupus, rheumatoid arthritis and scleroderma. As we
do today, we had a talented and devoted staff.” — Dr.
Lawrence E. Shulman, director emeritus
- The Osteoarthritis Initiative, a public-private partnership
to speed discovery of biological markers for changes in bone
or cartilage critical to diagnosing and monitoring OA, developing
new treatments and identifying people at risk for the disease
or its progression.
- A concerted effort to hasten scientific progress in our understanding
of the muscular dystrophies.
- Advances in therapies for osteoporosis and dramatic progress
in joint replacements.
- The Health Partnership Program, a collaborative effort between
NIAMS and local community representatives to reduce morbidity
and mortality associated with rheumatic diseases and their complications,
particularly in Washington, D.C.-area African-American and Hispanic/Latino
We remain committed to solving the mysteries of bone, joint, muscle
and skin conditions, and look forward to the discoveries the next
decade will bring!